TODAY, 176 MILLION WOMEN SUFFER FROM ENDOMETRIOSIS, BUT YOU WOULD HARDLY KNOW IT.

 
 

That's because in many ways, to describe the disease is to describe the invisible. With the DotEndo test, we're uncloaking endometriosis and filling the diagnostic gap that is over a century old.

 
edited.jpg

Clarity through science

Endometriosis is a complex, heterogeneous disease that may present inconsistently across patients. By measuring disease-specific biomarkers and applying advanced biostatistics, DotEndo provides the information you need to attribute her symptoms.

tumblr_mn8b8sLRb61rkz363o1_1280.jpg

ACTIONABLE AND NON-INVASIVE

DotEndo is being developed to empower women to end their diagnostic odyssey through providing a non-invasive option for endometriosis testing. This is more than a risk profile; this is an answer.

edited.jpg

Paradigm Shift

When did we accept that a woman can wait years for answers to her health? Did it begin when her physician mistook her chronic pain as “all in her head?” Was it when she paused at the thought of laparoscopy for diagnosis, not ready to face the physical, emotional, and financial burdens of surgery? At DotLab, we're ending the delay because an easy test means an early, actionable answer.

Bring DotEndo to your patients